Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization. Issue 3 (14th January 2020)

• Record Type: Journal Article
• Authors: Fowler, Stephen; Chen, Wen Li Kelly; Duignan, David B.; Gupta, Anshul; Hariparsad, Niresh; Kenny, Jane R.; Lai, W. George; Liras, Jennifer; Phillips, Jonathan A.; Gan, Jinping
• Is Part Of: Lab on a chip. Volume 20:Issue 3(2020)
• Page Start: 446
• Page End: 467
• Publication Date: 2020-01-14
• Subjects: Miniature electronic equipment -- Periodicals; Combinatorial chemistry -- Periodicals; Biotechnology -- Periodicals; 543.0813
• DOI: 10.1039/c9lc00857h
• Languages: English
• ISSNs: 1473-0197

Abstract

Abstract : Potential applications of MPS in the ADME discipline. Abstract : Over the last decade, progress has been made on the development of microphysiological systems (MPS) for absorption, distribution, metabolism, and excretion (ADME) applications. Central to this progress has been proof of concept data generated by academic and industrial institutions followed by broader characterization studies, which provide evidence for scalability and applicability to drug discovery and development. In this review, we describe some of the advances made for specific tissue MPS and outline the desired functionality for such systems, which are likely to make them applicable for practical use in the pharmaceutical industry. Single organ MPS platforms will be valuable for modelling tissue-specific functions. However, dynamic organ crosstalk, especially in the context of disease or toxicity, can only be obtained with the use of inter-linked MPS models which will enable scientists to address questions at the intersection of pharmacokinetics (PK) and efficacy, or PK and toxicity. In the future, successful application of MPS platforms that closely mimic human physiology may ultimately reduce the need for animal models to predict ADME outcomes and decrease the overall risk and cost associated with drug development.